Omega Therapeutics Inc

-0.02 (-1.10%)
: $1.80 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)99.25M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.5 Million
Adjusted EPS-$0.46
See more estimates
10-Day MA$1.85
50-Day MA$1.92
200-Day MA$5.15
See more pivots

Omega Therapeutics Inc Stock, NASDAQ:OMGA

140 First Street, Suite 501, Cambridge, Massachusetts 02141
United States of America
Phone: +1.617.949.4360
Number of Employees: 117


Omega Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of DNA-sequence-targeting and mRNA-encoded therapeutics. It offers its product under the OMEGA platform. The company was founded by Noubar B. Afeyan and David Berry on July 13, 2016 and is headquartered in Cambridge, MA.